Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Leon Medical Centers Partners with Health Tech Company Rimidi, Reducing A1Cs in High-Risk Cohort of Patients with Type 2 Diabetes

84% of patients being remotely monitored by Leon clinicians using Rimidi's platform have improved their A1C to below 9%


News provided by

Rimidi

Sep 14, 2021, 09:00 ET

Share this article

Share toX

Share this article

Share toX


MIAMI and ATLANTA, Sept. 14, 2021 /PRNewswire-PRWeb/ -- Leon Medical Centers, a leading healthcare services provider serving Medicare patients in South Florida, today announced clinical improvements in a cohort of high-risk patients with Type 2 Diabetes due to the remote patient monitoring and clinical decision support capabilities of Rimidi, a leading clinical management platform designed to optimize clinical workflows, enhance patient experiences and achieve quality objectives.

Leon began using the Rimidi platform, which integrates directly with their Epic electronic health record (EHR), at the beginning of 2020. Patients who are considered high-risk with hemoglobin A1Cs above 9% are given a SmartMeter iGlucose, a cellular-enabled glucometer and instructed by their doctor how often to take their blood-glucose reading. The data from iGlucose flows directly into the Rimidi platform, where it is curated alongside relevant clinical data from Epic. To date, approximately 225 high-risk patients have been enrolled to be remotely monitored by Leon clinicians. Now, 84% of those patients have been able to get their A1Cs below 9%, a key indicator of better diabetes control.

Finding partners that can effectively fit our healthcare delivery model has often been a challenge. However, Rimidi has provided us with a key patient service, allowing our organization to achieve yet another successful step towards the future of healthcare.

Post this

"At Leon, our motto is 'Medical Excellence and Personal Attention at All Times.' That's become more challenging—yet more important than ever—during the COVID-19 crisis" said Albert Maury, President and CEO of Leon Medical Centers. "Our partnership with Rimidi furthers our ability to meet each patient's unique needs proactively, whether at one of our medical centers or at their own home. Finding partners that can effectively fit our healthcare delivery model has often been a challenge. However, Rimidi has provided us with a key patient service, allowing our organization to achieve yet another successful step towards the future of healthcare."

A key differentiator in Rimidi's newly-enhanced platform compared to other remote monitoring providers is its highly configurable clinical decision support capabilities. Tight integration with Epic enables clinicians to not only set up decision support and alerts based off remotely generated data, but off of clinical data in the EHR as well. For example, Leon has configured Rimidi's clinical decision support cards to alert them to next best steps in care when individual patients are not meeting guidelines based on clinical outcomes in the EHR or self-monitoring data from the patient at home.

"Leon puts patient care and convenience first and recognizes that chronic conditions like Type 2 Diabetes require continual monitoring and support, not just during in-clinic appointments," said Lucienne Ide, MD, PhD, Founder and CEO of Rimidi. "Leon has done a great job leveraging our platform not just for RPM, but for Clinical Decision Support to ensure they're closing gaps in care according to the latest evidence-based guidelines. We are excited to share in their mission of providing the best patient experience and outcomes in south Florida."

As the only Healthcare Information and Management Systems Society (HIMSS) Stage 7 Outpatient Medical Care Institution in Miami-Dade County, Leon Medical Centers is applauded by HIMSS for its efforts to improve patient outcomes through the implementation of innovative healthcare technology. "Implementing Rimidi is a perfect example of Leon's continual commitment to using technology in improving patient care and why we are recognized as a twice-awarded HIMSS Stage 7 provider," Maury added.

The adoption of Rimidi's platform by Leon Medical Centers helps minimize risk of exposure to COVID-19 for both patients and staff by enabling the ability to virtually monitor patients with Type 2 Diabetes.

For more information about Leon Medical Centers and their commitment to better patient outcomes, visit leonmedicalcenters.com. To learn how Rimidi's platform can support your institution's needs, visit rimidi.com.

About Leon Medical Centers
Established in 1996, Leon Medical Centers has grown to become one of Miami's leading healthcare services providers, serving Medicare patients in seven conveniently located centers throughout Miami-Dade County, and at satellite locations in various South Florida partner hospitals. Learn more about Leon Medical Centers at http://www.leonmedicalcenters.com, and at @leon.medical on Instagram, @LeonMedicalCenters on Facebook, and @LeonMedical on Twitter.

About Rimidi
Created by doctors, Rimidi's leading clinical management platform empowers healthcare organizations to optimize clinical workflows, enhance patient experiences and achieve quality objectives. By bringing together clinical decision support, remote patient monitoring and patient reported outcomes in a unified, composable, FHIR-based platform, Rimidi supports a broad range of clinical use cases and institutional priorities across large and small healthcare organizations. For more information, visit rimidi.com and follow us on Facebook, Twitter and LinkedIn.

Media Contact

Cortney Williams, ARPR, on behalf of Rimidi, 855.300.8209, [email protected]

Twitter

SOURCE Rimidi

Related Links

http://Rimidi.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.